Haleon plc (NYSE:HLN) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Haleon plc (NYSE:HLN) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $10.95.

HLN has been the topic of several analyst reports. UBS Group raised Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday. Finally, Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday.

Institutional Trading of Haleon

Several large investors have recently bought and sold shares of HLN. FMR LLC increased its holdings in shares of Haleon by 5.8% during the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock worth $1,110,035,000 after buying an additional 5,768,117 shares in the last quarter. Sculptor Capital LP grew its position in Haleon by 67.8% during the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after acquiring an additional 3,592,000 shares during the last quarter. Clearbridge Investments LLC increased its holdings in Haleon by 8.6% in the 2nd quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock worth $344,888,000 after purchasing an additional 3,307,009 shares in the last quarter. Wellington Management Group LLP raised its position in Haleon by 49.9% in the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock valued at $96,833,000 after purchasing an additional 3,046,841 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Haleon by 25.3% during the third quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock valued at $53,791,000 after purchasing an additional 1,026,939 shares in the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Stock Down 4.0 %

NYSE HLN opened at $9.11 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a market cap of $41.24 billion, a price-to-earnings ratio of 26.79, a PEG ratio of 2.95 and a beta of 0.29. The company has a 50 day moving average of $9.61 and a 200-day moving average of $9.67. Haleon has a 1-year low of $7.89 and a 1-year high of $10.80.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.